In findings that have implications for potential new HIV therapies, researchers from Texas Biomedical Research Institute (Texas Biomed) used genetic sequencing techniques on the nonhuman primate version of the virus to identify that lymph nodes in the abdomen are the leading source of rebound infection after the first week of stopping antiretroviral treatment.
invIOs selects INV501 lead candidate to progress into IND-enabling studies in glioblastoma and melanoma – Biotech Investments
EQS-News: invIOs GmbH / Key word(s): Miscellaneous/Patent invIOs selects INV501 lead candidate to progress into IND-enabling studies in glioblastoma and melanoma 17.07.2024 / 10:00 CET/CEST